Physician

Ainsley Roberson Rusevlyan, DPM

According to 2025 Medicare claims, Ainsley Rusevlyan, DPM (NPI: 1851518393) practices podiatry, with the plurality of this provider's patient population coming from Beaufort, NC. This provider's primary affiliated billing organization is INSTRIDE FOOT AND ANKLE SPECIALISTS, PLLC (NPI: 1457601601; TIN: 300700851) and primary practice location at 27889-3841.

Rusevlyan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 658 traditional Medicare patients, billed 3,228 HCPCS/CPT codes, and received $1,335,273 in Medicare payments. The top billing code was 10061 (Complicated or multiple drainage of skin abscess). Part D data shows 1,928 prescription claims across 569 beneficiaries totaling $50,623 in drug costs, led by Lyrica (Pregabalin). 2022 DME data shows 11 claims. Open Payments data shows 4 records totaling $183. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $249,601 to $1,335,273. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $75,441 and ending at $50,623. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $11,362 and ending at $2,809.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,154	5,019	$249,601
2016	1,253	5,633	$276,627
2017	1,257	5,862	$274,404
2018	1,132	5,375	$260,703
2019	1,083	5,656	$250,561
2020	956	5,985	$499,186
2021	848	4,003	$288,819
2022	823	3,131	$246,283
2023	729	2,442	$189,595
2024	658	3,228	$1,335,273

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	423	1,530	$75,441
2016	449	1,372	$62,961
2017	449	1,287	$70,751
2018	457	1,287	$86,123
2019	447	1,099	$61,204
2020	449	1,368	$53,424
2021	511	1,611	$88,726
2022	569	1,764	$78,307
2023	610	1,958	$100,215
2024	569	1,928	$50,623

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	66	77	$10,769
2016	65	101	$15,212
2017	89	131	$12,441
2018	301	357	$66,615
2019	89	121	$9,731
2020	126	152	$32,414
2021	15	26	$1,379
2022	11	11	$2,521
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
10061	Complicated or multiple drainage of skin abscess	81	90	$131
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	204	204	$70
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	490	1,107	$60
11721	Removal of fingernails or toenails, 6 or more nails	131	215	$26
J1100	Injection, dexamethasone sodium phosphate, 1 mg	67	90	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lyrica	Pregabalin	13	364	$14,735
Duloxetine Hcl	Duloxetine Hcl	245	13,675	$4,321
Gabapentin	Gabapentin	373	16,492	$2,965
Pregabalin	Pregabalin	170	5,341	$2,746
Ketoconazole	Ketoconazole	78	2,169	$1,443

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$183	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ainsley Roberson Rusevlyan, DPM?

Tedicare shows public-source Medicare data for Ainsley Roberson Rusevlyan, DPM (NPI 1851518393), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ainsley Roberson Rusevlyan, DPM have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ainsley Roberson Rusevlyan, DPM?

Ainsley Roberson Rusevlyan, DPM is linked to INSTRIDE FOOT AND ANKLE SPECIALISTS, PLLC (billing NPI 1457601601) in the available physician profile data.

Does Ainsley Roberson Rusevlyan, DPM have Open Payments data?

Ainsley Roberson Rusevlyan, DPM has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.